Two French manufacturers of breast implants are offering discounts to women who have received faulty implants from scandal-hit rival PIP.

"/> Two French manufacturers of breast implants are offering discounts to women who have received faulty implants from scandal-hit rival PIP.

" />
Read news from:
Austria
SHARE
COPY LINK

HEALTH

Rival implant makers offer boob job discounts

Two French manufacturers of breast implants are offering discounts to women who have received faulty implants from scandal-hit rival PIP.

Published: 12 January 2012 11:54 CET
Rival implant makers offer boob job discounts
Webphotographeer

January sales in France kicked off on Wednesday with an unusual discount for women who have received faulty breast implants from defunct French manufacturer PIP. Rivals Sebbin and Cereplas are offering replacements at a knock-down rate.

Sebbin is offering to halve the price of implants for women who can prove they have received PIP implants, which have been shown to rupture more easily and are suspected of causing cancer. 

PIP was closed down by health authorities last year after they discovered the company was using non-medical silicone gel in implants which were twice as likely to rupture as other products in the same category.

The president of Sebbin, Olivier Pérusseau, says he is offering the discounts to show his solidarity with the victims of PIP implants. “We have a duty to show our support of women who suffered such as massive fraud,” he told weekly L’Express. 

HEALTH

Lengthy waiting times at Danish hospitals not going away yet: minister

Danish Minister for the Interior and Health Sophie Løhde has warned that, despite increasing activity at hospitals, it will be some time before current waiting lists are reduced.

Published: 10 May 2023 15:09 CEST
Lengthy waiting times at Danish hospitals not going away yet: minister

The message comes as Løhde was set to meet with officials from regional health authorities on Wednesday to discuss the progress of an acute plan for the Danish health system, launched at the end of last year in an effort to reduce a backlog of waiting times which built up during the coronavirus crisis.

An agreement with regional health authorities on an “acute” spending plan to address the most serious challenges faced by the health services agreed in February, providing 2 billion kroner by the end of 2024.

READ ALSO: What exactly is wrong with the Danish health system?

The national organisation for the health authorities, Danske Regioner, said to newspaper Jyllands-Posten earlier this week that progress on clearing the waiting lists was ahead of schedule.

Some 245,300 operations were completed in the first quarter of this year, 10 percent more than in the same period in 2022 and over the agreed number.

Løhde said that the figures show measures from the acute plan are “beginning to work”.

“It’s positive but even though it suggests that the trend is going the right way, we’re far from our goal and it’s important to keep it up so that we get there,” she said.

“I certainly won’t be satisfied until waiting times are brought down,” she said.

“As long as we are in the process of doing postponed operations, we will unfortunately continue to see a further increase [in waiting times],” Løhde said.

“That’s why it’s crucial that we retain a high activity this year and in 2024,” she added.

Although the government set aside 2 billion kroner in total for the plan, the regional authorities expect the portion of that to be spent in 2023 to run out by the end of the summer. They have therefore asked for some of the 2024 spending to be brought forward.

Løhde is so far reluctant to meet that request according to Jyllands-Posten.

SHOW COMMENTS